Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tine Norman Alver

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Plos One|June 18, 2014
Overexpression of SMPX in adult skeletal muscle does not change skeletal muscle fiber type or sizeEinar Eftestøl, Tine Norman Alver, Kristian Gundersen, et al.
Cancer Reports (Hoboken, N.J.)|October 17, 2022
Cooperative induction of receptor tyrosine kinases contributes to adaptive MAPK drug resistance in melanoma through the PI3K pathwayTine Norman Alver, Karen-Marie Heintz, Eivind Hovig, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 31, 2025
Spatial Transcriptomics Reveals Cancer and Stromal Cell Heterogeneity Between Center and Invasive Front of Pancreatic CancerTine Norman Alver, Helga Bergholtz, Maia Blomhoff Holm, et al.
Frontiers in Oncology|August 16, 2024
Thoracic radiation in combination with erlotinib-results from a phase 2 randomized trialHanne Marte Nymoen, Tine Norman Alver, Henrik Horndalsveen, et al.
Cancers|July 2, 2020
Dysregulation of MITF Leads to Transformation in MC1R-Defective MelanocytesTimothy J Lavelle, Tine Norman Alver, Karen-Marie Heintz, et al.
Molecular Oncology|November 4, 2022
Atezolizumab and stereotactic body radiotherapy in patients with advanced non-small cell lung cancer: safety, clinical activity and ctDNA responses-the ComIT-1 trialHenrik Horndalsveen, Tine Norman Alver, Astrid Marie Dalsgaard, et al.
Communications Medicine|April 30, 2026
Systematic interrogation of drug sensitivities in melanoma reveals potent synergistic and antagonistic drug combinations with translational potentialPilar Ayuda-Durán, Robert Hanes, Leiv Rønneberg, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Plos One|June 18, 2014
Overexpression of SMPX in adult skeletal muscle does not change skeletal muscle fiber type or sizeEinar Eftestøl, Tine Norman Alver, Kristian Gundersen, et al.
Cancer Reports (Hoboken, N.J.)|October 17, 2022
Cooperative induction of receptor tyrosine kinases contributes to adaptive MAPK drug resistance in melanoma through the PI3K pathwayTine Norman Alver, Karen-Marie Heintz, Eivind Hovig, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 31, 2025
Spatial Transcriptomics Reveals Cancer and Stromal Cell Heterogeneity Between Center and Invasive Front of Pancreatic CancerTine Norman Alver, Helga Bergholtz, Maia Blomhoff Holm, et al.
Frontiers in Oncology|August 16, 2024
Thoracic radiation in combination with erlotinib-results from a phase 2 randomized trialHanne Marte Nymoen, Tine Norman Alver, Henrik Horndalsveen, et al.
Cancers|July 2, 2020
Dysregulation of MITF Leads to Transformation in MC1R-Defective MelanocytesTimothy J Lavelle, Tine Norman Alver, Karen-Marie Heintz, et al.
Molecular Oncology|November 4, 2022
Atezolizumab and stereotactic body radiotherapy in patients with advanced non-small cell lung cancer: safety, clinical activity and ctDNA responses-the ComIT-1 trialHenrik Horndalsveen, Tine Norman Alver, Astrid Marie Dalsgaard, et al.
Communications Medicine|April 30, 2026
Systematic interrogation of drug sensitivities in melanoma reveals potent synergistic and antagonistic drug combinations with translational potentialPilar Ayuda-Durán, Robert Hanes, Leiv Rønneberg, et al.
Pageof 1